Document is current
Any future updates will be listed below
-
Authors
Minotti, Chiara https://orcid.org/0000-0003-3941-9952
Wallis, Lauren https://orcid.org/0009-0006-1787-9025
Hoesli, Jennifer
Schlaeppi, Chloé https://orcid.org/0009-0005-2195-2873
Nyantakyi, Emanuela https://orcid.org/0000-0002-7740-7680
Schultes, Marie-Therese https://orcid.org/0000-0002-1593-3247
Jost, Kerstin https://orcid.org/0000-0001-5634-0774
Bielicki, Julia Anna https://orcid.org/0000-0002-3902-5489
- License Information
-
More Information
Article History
Received: 5 February 2026
Revised: 10 March 2026
Accepted: 17 March 2026
First Online: 23 April 2026
Competing interests
: C.M., C.S., E.N. and M.S. received funding from EU Horizon 2020 through the NeoIPC Project (European Union’s Horizon 2020 research and innovation programme under grant agreement No 965328). K.J. received funding from EU Horizon 2020 through the NeoIPC Project (European Union’s Horizon 2020 research and innovation programme under grant agreement No 965328) and the Machaon Foundation. J.A.B. received funding from EU Horizon 2020 through the NeoIPC Project (European Union’s Horizon 2020 research and innovation programme under grant agreement No 965328); other grants from European and Developing Countries Clinical Trials Partnership, Swiss National Science Foundation, Swiss Personalised Health Network, State Secretariat for Education, Research and Innovation, Innosuisse, Joint Programming Initiative on Antimicrobial Resistance, Novartis Foundation, and Bill and Melinda Gates Foundation; consulting fees from Shionogi, Global Antibiotic Research and Development Partnership, and bioMérieux; payment or honoraria for lectures or presentations from bioMérieux; and had unpaid leadership roles in other board, society, committee for SwissPedNet and Penta Foundation.
: Given the nature of this study as a narrative literature synthesis, ethical approval was not required.
